7241-11-4
Chemical Structure
Meglumine Metrizoate
Synonym(s): Methylglucamine metrizoate
- CAS No.: 7241-11-4
- Formula:C19H28I3N3O9
- Molecular Weight:823.15
IUPAC Name: (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 3-acetamido-2,4,6-triiodo-5-(N-methylacetamido)benzoate
InChIKey: TXKOGNLDVKUFSI-WZTVWXICSA-N
SMILES: O=C(O)C1=C(I)C(N(C(C)=O)C)=C(I)C(NC(C)=O)=C1I.O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)CNC
Biological Activity: Meglumine Metrizoate (Methylglucamine metrizoate) is an ionic water-soluble contrast medium. Meglumine Metrizoate has a good imaging effect in cerebral angiography. Compared with the non-ionic contrast medium Metrizamide (HY-W000133), Meglumine Metrizoate has a higher probability of causing adverse effects such as EEG deterioration and bradycardia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Meglumine Metrizoate | Meglumine Metrizoate (Methylglucamine metrizoate) is an ionic water-soluble contrast medium. Meglumine Metrizoate has a good imaging effect in cerebral angiography. Compared with the non-ionic contrast medium Metrizamide (HY-W000133), Meglumine Metrizoate has a higher probability of causing adverse effects such as EEG deterioration and bradycardia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
